Read the full study: Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone (Horm Res 2000)
Confirming normal baseline organ function is a mandatory pretreatment assessment before safely initiating standard disease-modifying antirheumatic drugs (DMARDs) like methotrexate, which is strictly contraindicated in cases of liver disease or severe kidney impairment (Cohen & Mikuls, 2025
Besides these stage-specific effects, GHK-Cu and KPV@PPP_E also demonstrated antibacterial activity, which may further support inflammation resolution by reducing microbial burden
Li P, Fu L, Liao Z, Peng Y, Ning C, Gao C, et al
Mastroberardino Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
